Indogulf Cropsciences Limited (MAINBOARD)
June 26, 2025 – June 30, 2025
| Price | ₹105 - ₹111 |
| Premium | ₹11 |
|---|---|
| Lot size | 135 |
| Allotment | Jul 1, 2025 |
| Listing | Jul 3, 2025 |
About
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| Retail | 1 | 135 | 14985 | 46713 |
| sHNI | 14 | 1890 | 209790 | 477 |
| bHNI | 67 | 9045 | 1003995 | 953 |
IPO Details
| Total Issue Size | [.] shares (aggregating up to [200] Cr) |
| Fresh Issue | [.] shares (aggregating up to 160.00 Cr) |
| Offer for Sale | 36,03,603 shares of ?10 (aggregating up to ?[40] Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 4,87,87,456 shares |
IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Offer |
| Retail Shares Offered | Not less than 35% of the Offer |
| NII (HNI) Shares Offered | Not less than 15% of the Offer |
Key Performance Indicator (KPI)
| KPI | Dec-24 | Mar-24 | Mar-23 | Mar-22 |
|---|---|---|---|---|
| ROE | 8.17% | 12.19% | 11.03% | 14.60% |
| ROCE | 12.96% | 18.82% | 17.77% | 20.26% |
| EPS (basic) | 5.1 | 12 | 9.53 | 11.21 |
| P/E Pre IPO | ||||
| P/E Post IPO |
Company Financials In Crores
| Period Ended | Dec-24 | Mar-24 | Mar-23 | Mar-22 |
|---|---|---|---|---|
| Assets | 597.81 | 542.25 | 517.51 | 413.59 |
| Revenue | 466.31 | 555.79 | 552.19 | 490.23 |
| Profit After Tax | 21.68 | 28.23 | 22.42 | 26.36 |
| EBITDA | 44.78 | 55.74 | 49.04 | 47.24 |
| Net Worth | 265.43 | 231.65 | 203.25 | 180.51 |
| Reserves and Surplus | 216.64 | 208.01 | 179.6 | 156.87 |
| Total Borrowing | 206.3 | 154.56 | 189.22 | 101.38 |
Company Overview
Pioneering Capabilities: The company has played a significant role in the domestic agrochemical sector by being among the first to manufacture Spiromesifen technical (96.5% purity) and Pyrazosulfuron Ethyl technical (97% purity) indigenously, showcasing its innovation and technical prowess.
Manufacturing Infrastructure: Indogulf operates four manufacturing plants strategically located in Jammu & Kashmir (Samba) and Haryana (Nathupur and Barwasni), covering a combined area of approximately 20 acres. These multi-purpose, adaptable production units allow the company to handle a broad range of formulations and technical products, enhancing responsiveness to market needs.
Domestic and Global Presence: With a pan-India footprint across 22 states and 3 Union Territories, the company works with 5,772 distributors and 169 business partners, enabling strong market penetration. Globally, Indogulf maintains relationships with 129 partners across 34 countries, supporting its export operations and international recognition.
Competitive Edge: The company benefits from the high regulatory barriers inherent in the agrochemical industry—such as lengthy approval processes and high compliance costs—which help protect market position and limit new competition. Its ability to efficiently adapt production based on demand gives Indogulf a strategic edge in a dynamic industry.
Strength
Wide Domestic and Global Distribution Network: The company has a strong sales presence across 22 Indian states and 3 Union Territories, supported by over 5,700 distributors and 169 business partners, along with international reach in 34 countries.
Backward-Integrated Manufacturing Facilities: Indogulf’s in-house, multi-purpose production units across Jammu & Kashmir and Haryana ensure better control over quality, cost, and supply chain efficiency.
Robust R&D and Innovation Capabilities: The company demonstrates strong technical leadership, with a track record of pioneering products like Spiromesifen and Pyrazosulfuron Ethyl, supported by ongoing research and product development.
Weakness
Risk of Quality Control Failures: The company’s success relies heavily on strict adherence to quality standards. Any lapses could lead to order cancellations, loss of customer trust, or warranty claims, directly impacting revenue and reputation.
Brand Reputation Vulnerability: Negative publicity, product issues, or changes in branding could weaken brand value and customer perception, potentially affecting market share and financial performance.
Underutilization of Manufacturing Capacity: Inability to fully utilize existing or expanded production facilities may lead to increased costs and reduced profitability, posing challenges to long-term business growth.
Lead Manager(s)
Address
Plot No - D-9,
Netaji Subhash Place
Delhi, New Delhi, 110034
Phone: +91 11 4004 0417
Email: cs@groupindogulf.com
Website: http://www.groupindogulf.com/